SCHEDULE: Deep Track Capital Reports 2.96% Stake in Korro Bio

Deep Track Capital and affiliates disclose a 2.96% passive beneficial ownership stake in Korro Bio, Inc., holding 277,966 shares of common stock.

Summary

• Deep Track Capital, LP, Deep Track Biotechnology Master Fund, Ltd., and David Kroin collectively report beneficial ownership of 277,966 shares of Korro Bio, Inc. common stock.
• This ownership represents 2.96% of the total outstanding common stock of Korro Bio, Inc.
• The percentage of class is calculated based on 9,390,492 common shares outstanding as of May 5, 2025, as reported in Korro Bio's Form 10-Q filed with the SEC on May 7, 2025.
• The reporting persons have shared voting and shared dispositive power over all 277,966 beneficially owned shares.
• The securities were not acquired and are not held for the purpose or with the effect of changing or influencing the control of Korro Bio, Inc.

Sentiment

Score: 5

Explanation: This is a routine Schedule 13G filing disclosing a passive ownership stake below the 5% threshold, indicating an investment but no intent to influence control. It is a neutral event.

Positives

• Deep Track Capital, a specialized investment firm, has taken a passive stake in Korro Bio, Inc., indicating their investment interest in the company.

Risks

• The reporting persons certify that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities, and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 14a-11.

Future Outlook

The reporting persons have certified that their acquisition and holding of shares are not for the purpose of changing or influencing the control of the issuer, indicating a passive investment strategy.

Industry Context

Deep Track Capital, an investment firm focused on the biotechnology sector, has disclosed a passive stake in Korro Bio, Inc., aligning with their specialized investment strategy within the biotech industry.

Stakeholder Impact

• Shareholders: Awareness of an institutional investor, Deep Track Capital, holding a passive stake in the company.

Key Dates

Keywords

Korro Bio, Deep Track Capital, beneficial ownership, common stock, SEC filing, Schedule 13G, biotechnology, investment